3.1
This guidance requires that clinicians undertaking the procedure make special arrangements for audit. NICE has identified relevant audit criteria and developed an audit tool (which is for use at local discretion).
3 Further information
3.2
NICE has produced HealthTech guidance on photodynamic therapy (PDT) for early-stage oesophageal cancer, palliative PDT for advanced oesophageal cancer, epithelial radiofrequency ablation for Barrett's oesophagus, PDT for localised inoperable endobronchial cancer, PDT for advanced bronchial carcinoma, PDT for bile duct cancer and PDT for non-melanoma skin tumours.